NASDAQ: ETON
Eton Pharmaceuticals Inc Stock Ownership - Who owns Eton Pharmaceuticals?

Insider buying vs selling

Have Eton Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Norbert G. RiedelDirector2025-01-0325,000$3.47
$86.75kBuy
Norbert G. RiedelDirector2025-01-0350,000$3.78
$189.00kBuy
Norbert G. RiedelDirector2025-01-0327,400$3.58
$98.09kBuy
Opaleye Management Inc10% Owner2024-10-2310,000$7.98
$79.81kBuy
Opaleye Management Inc10% Owner2024-10-083,970$7.03
$27.91kBuy
Opaleye Management Inc10% Owner2024-10-0830,000$7.03
$210.87kBuy
Opaleye Management Inc10% Owner2024-10-0710,000$7.22
$72.23kBuy
Opaleye Management Inc10% Owner2024-10-071,248$7.22
$9.01kBuy
Opaleye Management Inc10% Owner2024-10-0415,000$6.77
$101.57kBuy
Opaleye Management Inc10% Owner2024-10-041,852$6.77
$12.54kBuy

1 of 2

ETON insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ETON insiders and whales buy or sell their stock.

ETON Shareholders

What type of owners hold Eton Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Opaleye Management Inc10.64%2,852,070$39.19MInsider
Opaleye Management Inc10.64%2,852,070$39.19MInstitution
Harrow Health Inc7.39%1,982,000$27.23MInsider
Ecor1 Capital LLC6.82%1,829,603$25.14MInstitution
Nantahala Capital Management LLC4.17%1,118,483$15.37MInstitution
Sean Brynjelsen3.97%1,064,940$14.63MInsider
Vanguard Group Inc3.97%1,063,707$14.62MInstitution
Westside Investment Management Inc2.14%575,222$7.90MInstitution
Mink Brook Asset Management LLC1.70%455,805$6.26MInstitution
Cannell Capital LLC1.42%381,323$5.24MInstitution

1 of 3

ETON vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ETON48.98%22.99%Net BuyingNet Buying
ESPR63.68%20.67%Net SellingNet Selling
KMDA10.63%0.00%
AQST43.87%7.62%Net SellingNet Selling
SIGA35.77%64.23%Net SellingNet Selling

Eton Pharmaceuticals Stock Ownership FAQ

Who owns Eton Pharmaceuticals?

Eton Pharmaceuticals (NASDAQ: ETON) is owned by 48.98% institutional shareholders, 22.99% Eton Pharmaceuticals insiders, and 28.03% retail investors. Opaleye Management Inc is the largest individual Eton Pharmaceuticals shareholder, owning 2.85M shares representing 10.64% of the company. Opaleye Management Inc's Eton Pharmaceuticals shares are currently valued at $38.16M.

If you're new to stock investing, here's how to buy Eton Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.